Newsmeme!
Discover News you didn't know existed
Kings Schools officials said Tuesday evening that expected declines in state funding might have them going to voters for more money in 2009 or 2010.
Protalix BioTherapeutics, Inc. (Amex: PLX), announced today that it has completed enrollment in the Company’s pivotal phase III clinical trial of prGCD, a proprietary plant cell expressed recombinant form of human glucocerebrosidase (GCD) for the treatment of Gaucher disease. Gaucher disease is a rare and serious lysosomal storage disorder in humans.
CARMIEL, Israel----Protalix BioTherapeutics, Inc. , announced today that it has completed enrollment in the Company’s pivotal phase III clinical trial of prGCD, a proprietary plant cell expressed recombinant form of human glucocerebrosidase for the treatment of Gaucher disease.
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced today that the launch of its Phase 2a Human Vaccine Trials will take place in twelve sites across North and South America.
On "Black Friday," the day after Thanksgiving and traditionally the busiest shopping day of the year, shoppers were busy throughout Wildwood's Town Center commercial area along Old Manchester Road and highways 100 and 109.
We are two Hollister residents who want to speak up for "Gilroy Gardens" the wonderful park that you have in your community. We love it, and so do the thousands of people who come to see it every week. They enjoy its beauty, the entertainment of its rides, and the joy of sharing it as a families.
GeoVax Labs Inc.’s phase 2a human HIV vaccine trials are set for sites across North and South America, the Atlanta biotechnology company said Monday.
Prana Biotechnology Limited today provided an update of highlights of current and future activities of the Company at the Annual General Meeting.
In this tale of two airports, it's the worst of times.
Proteolix, Inc., a leader in the discovery and development of novel therapeutics that target protein degradation pathways in cancer and autoimmune diseases, would present the data from two ongoing phase II clinical trials of carfilzomib in multiple myeloma at the upcoming 50th annual meeting of the American Society of Haematology (ASH). The ASH conference will be held from December 6 to 9, 2008 ...
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |